a strong trendp = 0.06
Significant effects were observed exclusively for somatization (Δ = 3.6; p < 0.05), together with a strong trend for anxiety symptoms (Δ = 2.6; p = 0.06) in the BSI-18 questionnaire.
Significant effects were observed exclusively for somatization (Δ = 3.6; p < 0.05), together with a strong trend for anxiety symptoms (Δ = 2.6; p = 0.06) in the BSI-18 questionnaire.
The migraine patients presented significantly greater anxiety symptoms (BSI-18) and nearly statistically significant levels of anxiety (STAI-trait) compared to participants without migraine, regardless of TMD, although no significant differences were found in state anxiety.